loading

Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten

pulisher
09:05 AM

Big Money Moves: Can Processa Pharmaceuticals Inc maintain sales growth2025 Analyst Calls & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

09:05 AM
pulisher
Jan 27, 2026

Patterns Watch: Does Processa Pharmaceuticals Inc align with a passive investing strategy - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 27, 2026

ETF Watch: Will Processa Pharmaceuticals Inc benefit from current market trendsQuarterly Trade Review & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 27, 2026

Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - lcsun-news.com

Jan 27, 2026
pulisher
Jan 25, 2026

Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - recordonline.com

Jan 25, 2026
pulisher
Jan 22, 2026

Risk Hedge: Is Processa Pharmaceuticals Inc showing insider buyingRate Cut & Step-by-Step Swing Trade Plans - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Processa Pharmaceuticals completes enrollment of 20th patient in Phase 2 study - MSN

Jan 22, 2026
pulisher
Jan 18, 2026

Will Processa Pharmaceuticals Inc. benefit from current market trendsBull Run & AI Enhanced Execution Alerts - bollywoodhelpline.com

Jan 18, 2026
pulisher
Jan 14, 2026

Stock Recap: Is Processa Pharmaceuticals Inc showing insider buying2025 Market WrapUp & Real-Time Market Sentiment Reports - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 12, 2026

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 12, 2026
pulisher
Jan 12, 2026

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference to Discuss NGC-Cap Phase 2 Study Results - Quiver Quantitative

Jan 12, 2026
pulisher
Jan 12, 2026

Breast cancer trial data in focus as Processa joins major health event - Stock Titan

Jan 12, 2026
pulisher
Jan 10, 2026

Is Processa Pharmaceuticals Inc. stock supported by strong cash flowsMarket Risk Report & Fast Gain Swing Trade Alerts - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

How Processa Pharmaceuticals Inc. stock reacts to oil pricesWeekly Gains Summary & Technical Buy Zone Confirmation - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

User - FinancialContent

Jan 09, 2026
pulisher
Jan 08, 2026

Will Processa Pharmaceuticals Inc. stock outperform value stocksLayoff News & Capital Efficiency Focused Strategies - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Biostar Pharmaceuticals (OTCMKTS:BSPM) versus Heatwurx (NASDAQ:PCSA) Critical Review - Defense World

Jan 08, 2026
pulisher
Jan 07, 2026

Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance - TipRanks

Jan 07, 2026
pulisher
Jan 06, 2026

Processa Pharmaceuticals shares surge on encouraging cancer trial update - MSN

Jan 06, 2026
pulisher
Jan 06, 2026

Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study - Investing.com Nigeria

Jan 06, 2026
pulisher
Jan 05, 2026

Processa Pharmaceuticals (PCSA) Advances in Phase 2 Cancer Study - GuruFocus

Jan 05, 2026
pulisher
Jan 05, 2026

Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study By Investing.com - Investing.com South Africa

Jan 05, 2026
pulisher
Jan 05, 2026

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - The Manila Times

Jan 05, 2026
pulisher
Jan 01, 2026

Processa Pharmaceuticals Inc. (PCSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 01, 2026
pulisher
Dec 30, 2025

User | chroniclejournal.comProcessa Pharmaceuticals, Inc.Common Stock (Nasdaq:PCSA) Stock Quote - FinancialContent

Dec 30, 2025
pulisher
Dec 29, 2025

Why did Processa Pharmaceuticals stock surge 160% today? - MSN

Dec 29, 2025
$97.44
price down icon 2.30%
$100.82
price down icon 2.49%
$32.91
price down icon 4.35%
$115.61
price down icon 3.06%
$159.85
price down icon 1.70%
biotechnology ONC
$347.73
price up icon 3.20%
Kapitalisierung:     |  Volumen (24h):